Is the type of biomesh relevant in the prevention of recurrence following abdominal wall reconstruction? A randomized controlled trial.

Background: Complex abdominal wall reconstruction technique remains controversial. The use of biologic mesh products is also debated in active infection, sepsis prophylaxis and high-risk patients. Differences in biologic mesh technology and cost remain significant.

Performance of biological mesh materials in abdominal wall reconstruction: study protocol for a randomised controlled trial.

Introduction: Abdominal wall hernias are a common source of morbidity and mortality. The use of biological mesh has become an important adjunct in successful abdominal wall reconstruction. There are a variety of biological mesh products available; however, there is limited evidence supporting the use of one type over another.

Trends in the Canadian Surgery Forum (CSF): analysis of the CSF program over the past decade.

Numerous clinical and basic science-related innovations have been presented at the Canadian Surgery Forum (CSF). We sought to define changes in both the content and methodology of the CSF scientific program over the past decade. While the total volume of CSF abstract presentations has increased dramatically, the methodological quality has remained static, with few randomized trials and minimal prospective work.